An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe ...

Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported. Several valve repair and replacement technologies, ...

Please provide your email address to receive an email when new articles are posted on . In patients who had mitral valve surgery but also tricuspid regurgitation or tricuspid annular dilation, ...

LONDON, England—All going to plan, the next few years should deliver some concrete results for transcatheter devices being tested for tricuspid regurgitation (TR). In the meantime, experts working in ...

Patients with moderate tricuspid regurgitation (TR) undergoing surgery for mitral valve disease have a significant improvement in TR grade, according to the results of a new study. In early ...

Delirium occurred in nearly 1-in-10 elderly patients after percutaneous mitral and tricuspid valve repair and signaled longer hospital stays and worse survival, a new study shows. Mortality was nearly ...

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...

Catheter-based delivery of replacement valves is established practice for patients with aortic regurgitation, but the mitral valve has only repair devices to address this condition. However, ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.

OR YEHUDA, Israel--(BUSINESS WIRE)--Cardiovalve announced today that it has received U.S. Food and Drug Administration (FDA) approval for an Early Feasibility Study (EFS) of its Transcatheter ...

DALLAS, Nov. 13, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may benefit by having both valves repaired at the same time, including a ...